|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.50 CHF | -0.45% |
|
-1.48% | +18.94% |
| Dec. 12 | Swiss Market Index Ends Week Downbeat; UBS Group Soars | MT |
| Dec. 12 | Novartis AG Breaks Ground on Flagship Manufacturing Hub in North Carolina | CI |
| Capitalization | 254B 217B 202B 190B 350B 23,033B 383B 2,355B 914B 10,859B 955B 934B 39,626B | P/E ratio 2025 * |
18.3x | P/E ratio 2026 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise value | 274B 234B 218B 205B 378B 24,839B 413B 2,539B 986B 11,711B 1,029B 1,007B 42,733B | EV / Sales 2025 * |
4.95x | EV / Sales 2026 * | 4.91x |
| Free-Float |
87.19% | Yield 2025 * |
3.08% | Yield 2026 * | 3.21% |
Last Transcript: Novartis AG
| 1 day | -0.45% | ||
| 1 week | -1.48% | ||
| Current month | +0.98% | ||
| 1 month | -0.23% | ||
| 3 months | +6.73% | ||
| 6 months | +8.58% | ||
| Current year | +18.94% |
| 1 week | 103.14 | 107.88 | |
| 1 month | 99.45 | 108.18 | |
| Current year | 81.1 | 108.18 | |
| 1 year | 81.1 | 108.18 | |
| 3 years | 73.74 | 108.18 | |
| 5 years | 72.84 | 108.18 | |
| 10 years | 65.09 | 108.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 2018-01-31 | |
| Director of Finance/CFO | 60 | 2013-04-23 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 66 | 2014-12-31 |
Liz Doherty
BRD | Director/Board Member | 68 | 2015-12-31 |
Ton Büchner
BRD | Director/Board Member | 60 | 2015-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -1.48% | +20.24% | +24.41% | 254B | ||
| +1.80% | +1.70% | +30.21% | +186.49% | 920B | ||
| +0.75% | +4.78% | +44.31% | +18.06% | 510B | ||
| -0.29% | -1.22% | +28.81% | +35.52% | 395B | ||
| -0.35% | +1.90% | +25.12% | +3.11% | 340B | ||
| -1.12% | -1.09% | +28.43% | +18.70% | 278B | ||
| +1.30% | +0.58% | -1.67% | -9.57% | 249B | ||
| +0.45% | +3.73% | -57.41% | -30.85% | 224B | ||
| +0.11% | -3.68% | +17.41% | +16.70% | 171B | ||
| -2.28% | -0.68% | +31.08% | +35.66% | 149B | ||
| Average | -0.01% | +0.45% | +16.65% | +29.82% | 349.14B | |
| Weighted average by Cap. | +0.42% | +1.07% | +22.26% | +59.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 55.48B 47.27B 44.11B 41.48B 76.38B 5,023B 83.56B 514B 199B 2,368B 208B 204B 8,641B | 56.73B 48.34B 45.1B 42.42B 78.1B 5,136B 85.45B 525B 204B 2,422B 213B 208B 8,837B |
| Net income | 14.37B 12.24B 11.42B 10.74B 19.78B 1,301B 21.64B 133B 51.65B 613B 53.91B 52.76B 2,238B | 14.27B 12.16B 11.35B 10.67B 19.65B 1,292B 21.5B 132B 51.3B 609B 53.55B 52.41B 2,223B |
| Net Debt | 19.95B 17B 15.86B 14.92B 27.46B 1,806B 30.05B 185B 71.71B 852B 74.85B 73.25B 3,107B | 24.17B 20.59B 19.22B 18.07B 33.27B 2,188B 36.4B 224B 86.88B 1,032B 90.69B 88.75B 3,765B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 105.50 CHF | -0.45% | 1,978,600 |
| 25-12-11 | 105.98 CHF | +0.53% | 2,333,253 |
| 25-12-10 | 105.42 CHF | -1.31% | 3,227,200 |
| 25-12-09 | 106.82 CHF | +0.17% | 2,451,246 |
| 25-12-08 | 106.64 CHF | -0.41% | 3,019,489 |
Delayed Quote Swiss Exchange, December 12, 2025 at 11:31 am EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions


















